Surmodics Return on Tangible Equity 2010-2025 | SRDX

Current and historical return on tangible equity values for Surmodics (SRDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Surmodics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.02B $0.05B -41.03%
2024-12-31 $-0.02B $0.05B -29.13%
2024-09-30 $-0.01B $0.05B -22.86%
2024-06-30 $0.00B $0.05B -3.81%
2024-03-31 $0.01B $0.06B 26.00%
2023-12-31 $0.01B $0.05B 11.49%
2023-09-30 $0.00B $0.05B -5.10%
2023-06-30 $-0.02B $0.04B -65.75%
2023-03-31 $-0.04B $0.03B -94.27%
2022-12-31 $-0.03B $0.04B -72.13%
2022-09-30 $-0.03B $0.04B -54.63%
2022-06-30 $-0.01B $0.05B -23.42%
2022-03-31 $-0.01B $0.06B -14.71%
2021-12-31 $0.00B $0.06B 2.51%
2021-09-30 $0.01B $0.06B 5.63%
2021-06-30 $0.00B $0.10B 2.06%
2021-03-31 $0.01B $0.10B 7.41%
2020-12-31 $0.00B $0.09B 0.00%
2020-09-30 $0.00B $0.09B 0.00%
2020-06-30 $0.01B $0.09B 8.19%
2020-03-31 $0.01B $0.09B 7.34%
2019-12-31 $0.01B $0.08B 7.64%
2019-09-30 $0.01B $0.08B 9.30%
2019-06-30 $0.00B $0.08B 1.41%
2019-03-31 $0.00B $0.07B -4.44%
2018-12-31 $0.00B $0.07B -3.04%
2018-09-30 $-0.01B $0.06B -7.81%
2018-06-30 $0.00B $0.06B -4.69%
2018-03-31 $0.00B $0.07B 1.57%
2017-12-31 $0.00B $0.06B 0.00%
2017-09-30 $0.00B $0.06B 6.48%
2017-06-30 $0.01B $0.06B 11.62%
2017-03-31 $0.01B $0.06B 17.17%
2016-12-31 $0.01B $0.06B 18.26%
2016-09-30 $0.01B $0.06B 20.37%
2016-06-30 $0.01B $0.05B 15.06%
2016-03-31 $0.01B $0.05B 13.58%
2015-12-31 $0.01B $0.06B 15.07%
2015-09-30 $0.01B $0.08B 15.69%
2015-06-30 $0.01B $0.08B 16.61%
2015-03-31 $0.01B $0.08B 16.35%
2014-12-31 $0.01B $0.07B 14.91%
2014-09-30 $0.01B $0.09B 14.63%
2014-06-30 $0.01B $0.08B 17.39%
2014-03-31 $0.01B $0.08B 16.05%
2013-12-31 $0.02B $0.08B 17.91%
2013-09-30 $0.02B $0.08B 17.44%
2013-06-30 $0.01B $0.09B 16.23%
2013-03-31 $0.01B $0.09B 14.14%
2012-12-31 $0.01B $0.09B 10.93%
2012-09-30 $0.01B $0.08B 9.11%
2012-06-30 $-0.01B $0.14B -8.37%
2012-03-31 $-0.01B $0.13B -7.62%
2011-12-31 $-0.01B $0.13B -7.65%
2011-09-30 $-0.02B $0.13B -14.48%
2011-06-30 $-0.02B $0.14B -16.60%
2011-03-31 $-0.03B $0.13B -20.34%
2010-12-31 $-0.03B $0.13B -21.64%
2010-09-30 $-0.02B $0.13B -15.56%
2010-06-30 $0.00B $0.14B 2.95%
2010-03-31 $0.01B $0.14B 6.74%
2009-12-31 $0.01B $0.14B 10.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.412B $0.126B
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.799B 28.11
Boston Scientific (BSX) United States $157.605B 39.46
Stryker (SYK) United States $150.214B 31.41
EssilorLuxottica (ESLOY) France $126.765B 0.00
Medtronic (MDT) Ireland $110.324B 15.64
Lonza Group Ag (LZAGY) Switzerland $50.804B 0.00
Haleon (HLN) United Kingdom $46.650B 26.61
ResMed (RMD) United States $37.413B 28.10
GE HealthCare Technologies (GEHC) United States $34.057B 16.17
Agilent Technologies (A) United States $33.852B 22.07
Terumo (TRUMY) Japan $27.835B 36.15
Koninklijke Philips (PHG) Netherlands $23.245B 16.31
Insulet (PODD) United States $22.033B 86.49
Zimmer Biomet Holdings (ZBH) United States $18.095B 11.62
Baxter (BAX) United States $15.595B 11.64
Smith & Nephew SNATS (SNN) United Kingdom $13.236B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.639B 23.10
Lantheus Holdings (LNTH) United States $5.638B 14.22
Prestige Consumer Healthcare (PBH) United States $3.998B 17.86
Perrigo (PRGO) Ireland $3.649B 9.25
Haemonetics (HAE) United States $3.545B 16.15
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.334B 27.70
ICU Medical (ICUI) United States $3.244B 23.92
GN Store Nord (GNNDY) Denmark $2.307B 19.11
QuidelOrtho (QDEL) United States $1.952B 13.43
LeMaitre Vascular (LMAT) United States $1.866B 41.70
AtriCure (ATRC) United States $1.598B 0.00
AdaptHealth (AHCO) United States $1.289B 13.08
Acuren (TIC) United States $1.271B 0.00
Green Thumb Industries (GTBIF) United States $1.111B 25.00
Phibro Animal Health (PAHC) United States $1.040B 13.30
Neogen (NEOG) United States $1.027B 13.14
BioLife Solutions (BLFS) United States $1.021B 0.00
Kestra Medical Technologies (KMTS) United States $0.907B 0.00
InMode (INMD) Israel $0.897B 9.04
Owens & Minor (OMI) United States $0.685B 5.69
CeriBell (CBLL) United States $0.683B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.629B 0.00
Evolus (EOLS) United States $0.589B 0.00
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Capricor Therapeutics (CAPR) United States $0.509B 0.00
Valneva SE (VALN) France $0.494B 0.00
Tilray Brands (TLRY) Canada $0.403B 0.00
VAREX IMAGING (VREX) United States $0.354B 13.00
Quanterix (QTRX) United States $0.332B 0.00
SNDL (SNDL) Canada $0.323B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Viemed Healthcare (VMD) United States $0.274B 23.07
Cerus (CERS) United States $0.271B 0.00
ZimVie (ZIMV) United States $0.258B 11.72
Sanuwave Health (SNWV) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.253B 0.00
Brainsway (BWAY) Israel $0.250B 66.10
Cresco Labs (CRLBF) United States $0.246B 0.00
Aurora Cannabis (ACB) Canada $0.233B 69.17
Biote (BTMD) United States $0.230B 6.46
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.224B 0.00
TriSalus Life Sciences (TLSI) United States $0.201B 0.00
Utah Medical Products (UTMD) United States $0.188B 15.29
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.184B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.120B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Fonar (FONR) United States $0.092B 11.90
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.085B 0.00
Apyx Medical (APYX) United States $0.082B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.077B 0.00
Cytosorbents (CTSO) United States $0.077B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
MacroGenics (MGNX) United States $0.075B 0.00
InterCure (INCR) Israel $0.068B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.061B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Nephros (NEPH) United States $0.041B 55.14
United-Guardian (UG) United States $0.037B 12.94
Modular Medical (MODD) United States $0.037B 0.00
Rockwell Medical (RMTI) United States $0.027B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00